Some of the thorniest problems in medicine that AI can improve have nothing to do with diagnosis. They have to do with triage ...

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

GLP-1 drugs first made their mark in diabetes and obesity, but many research efforts are underway to bring such therapies to more indications. Altimmune now has mid-stage clinical trial results ...

HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy.

City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The ...

Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah ...

Health care routinely recommends movement without providing assessment, dosage, progression, and follow-up that turn good ...

The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator ...

Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems ...

Happy Health has received FDA clearance for its wearable ring, which continuously measures blood pressure without a cuff or ...

Earlier detection is valuable, but it creates a duty that does not end when an alert appears in the electronic health record.

Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say ...